Lexicon Pharmaceuticals
LXRX
#7493
Rank
ยฃ0.30 B
Marketcap
ยฃ0.85
Share price
-19.44%
Change (1 day)
28.42%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2025 (TTM): -ยฃ0.15

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.14. In 2024 the company made an earnings per share (EPS) of -ยฃ0.47 an increase over its 2023 EPS that were of -ยฃ0.58.

EPS history for Lexicon Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.15-68.27%
2024-ยฃ0.47-20%
2023-ยฃ0.5831.15%
2022-ยฃ0.45-0%
2021-ยฃ0.4510.91%
2020-ยฃ0.40-145.08%
2019ยฃ0.89-206.09%
2018-ยฃ0.84-5.74%
2017-ยฃ0.89-10.95%
2016-ยฃ1.002640%
2015-ยฃ0.03654-96.34%
2014-ยฃ1.00-2.53%
2013-ยฃ1.02-9.09%
2012-ยฃ1.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ12.67-9,226.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ3.27-2,452.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ31.74-22,963.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ4.34 3,026.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.75-1,357.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.37 163.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.55 294.74%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.99-1,531.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ56.05 40,273.68%๐Ÿ‡บ๐Ÿ‡ธ USA